Retrospective survey of unselected hospital patients with and without cancer comparing outcomes following venous thromboembolism

Internal Medicine Journal

Volumn 32, Issue 9, 2002, Pages 437-444

  Cook, N ^a   Thomas, D M ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cancer; Survival; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEALTH STATUS; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0036046295     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00249.x     Document Type: Article

References (19)

1. Trouseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathologic and therapeutic features
2. Antithrombotic strategies in patients with cancer
3. Thrombosis in patients with cancer
4. Diagnosis and treatment of cancer-related thrombosis
5. Efficacy and safety of oral anticoagulation in patients with cancer
6. Thromboembolism in cancer. Changing trends
7. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ration: A retrospective analysis
8. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota
9. Prognosis of cancers associated with venous thromboembolism
10. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
11. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
12. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
13. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: A meta-analysis of randomised clinical trials
14. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
15. Deep-vein thrombosis
16. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review
17. Low-molecular-weight heparin versus standard heparin for the treatment of deep-vein thrombosis: A meta-analysis
18. Low-molecular-weight heparin in the management of Trousseau's syndrome